CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
hyperinsulinemic-euglycemic clampdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02717832
NCT02717832N/ACompleted
CompareCT.gov

Protection Against Insulin Resistance in Obesity

University of Michigan·interventional·Posted Mar 24, 2016·Updated May 11, 2022

In Brief

A clinical study evaluating hyperinsulinemic-euglycemic clamp for Obesity and Insulin Resistance. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The overall goal of this project is to identify factors that "protect" some obese adults from becoming insulin resistant. Identifying mechanisms that help protect some obese adults from developing insulin resistance could lead to novel, targeted therapeutic and/or preventative strategies for obese adults who are insulin resistant.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Insulin Resistance
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 24, 2016
Enrollment StartMar 1, 2016
Primary CompletionAug 9, 2019
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 10.3 years ago

Interventions

hyperinsulinemic-euglycemic clampdrug